HK1076034A1 - Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases - Google Patents

Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases

Info

Publication number
HK1076034A1
HK1076034A1 HK05108135A HK05108135A HK1076034A1 HK 1076034 A1 HK1076034 A1 HK 1076034A1 HK 05108135 A HK05108135 A HK 05108135A HK 05108135 A HK05108135 A HK 05108135A HK 1076034 A1 HK1076034 A1 HK 1076034A1
Authority
HK
Hong Kong
Prior art keywords
aspirin
medicament
manufacture
antithrombotic agent
novel association
Prior art date
Application number
HK05108135A
Other languages
English (en)
Inventor
Tony Verbeuren
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1076034A1 publication Critical patent/HK1076034A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK05108135A 2002-04-05 2005-09-16 Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases HK1076034A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
HK1076034A1 true HK1076034A1 (en) 2006-01-06

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108135A HK1076034A1 (en) 2002-04-05 2005-09-16 Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases

Country Status (27)

Country Link
US (1) US7618955B2 (xx)
EP (1) EP1496884B1 (xx)
JP (1) JP4065853B2 (xx)
KR (1) KR100645143B1 (xx)
CN (1) CN1297265C (xx)
AR (1) AR039253A1 (xx)
AT (1) ATE329591T1 (xx)
AU (1) AU2003246774B2 (xx)
BR (1) BR0309019A (xx)
CA (1) CA2480697A1 (xx)
CY (1) CY1105106T1 (xx)
DE (1) DE60306133T2 (xx)
DK (1) DK1496884T3 (xx)
EA (1) EA006978B1 (xx)
ES (1) ES2264533T3 (xx)
FR (1) FR2838057B1 (xx)
GE (1) GEP20074101B (xx)
HK (1) HK1076034A1 (xx)
MA (1) MA27114A1 (xx)
MX (1) MXPA04009760A (xx)
NO (1) NO20044700L (xx)
NZ (1) NZ535430A (xx)
PL (1) PL371620A1 (xx)
PT (1) PT1496884E (xx)
UA (1) UA79457C2 (xx)
WO (1) WO2003084525A1 (xx)
ZA (1) ZA200407593B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1906966A2 (en) * 2005-07-22 2008-04-09 The Procter and Gamble Company Compositions for reducing the incidence of drug induced arrhythmia
CN101743001B (zh) 2007-04-13 2013-02-06 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
PL371620A1 (en) 2005-06-27
MA27114A1 (fr) 2004-12-20
ES2264533T3 (es) 2007-01-01
US20050143354A1 (en) 2005-06-30
CN1646111A (zh) 2005-07-27
KR100645143B1 (ko) 2006-11-10
AU2003246774A1 (en) 2003-10-20
WO2003084525A1 (fr) 2003-10-16
GEP20074101B (en) 2007-05-10
JP4065853B2 (ja) 2008-03-26
EA006978B1 (ru) 2006-06-30
MXPA04009760A (es) 2004-12-13
CY1105106T1 (el) 2009-11-04
NZ535430A (en) 2006-09-29
PT1496884E (pt) 2006-09-29
AR039253A1 (es) 2005-02-16
BR0309019A (pt) 2005-02-01
ATE329591T1 (de) 2006-07-15
CN1297265C (zh) 2007-01-31
KR20040098053A (ko) 2004-11-18
EA200401293A1 (ru) 2005-02-24
FR2838057B1 (fr) 2005-07-08
DK1496884T3 (da) 2006-10-02
DE60306133D1 (de) 2006-07-27
US7618955B2 (en) 2009-11-17
EP1496884A1 (fr) 2005-01-19
ZA200407593B (en) 2006-07-26
NO20044700L (no) 2004-10-29
JP2005528376A (ja) 2005-09-22
DE60306133T2 (de) 2007-01-04
EP1496884B1 (fr) 2006-06-14
FR2838057A1 (fr) 2003-10-10
CA2480697A1 (fr) 2003-10-16
AU2003246774B2 (en) 2007-02-15
UA79457C2 (en) 2007-06-25

Similar Documents

Publication Publication Date Title
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
EP1487446A4 (en) BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES
HK1075832A1 (en) Use of an alpha helical apolipoprotein of hdl assiociated protein for the manufacture of a medicament adapted to be administered locally to prevent ortreat restenosis
AU2003220317A8 (en) Methods and drug delivery systems for the treatment of orofacial diseases
IL166256A (en) Use of interferon - ?? in the manufacture of a medicament for treating renal failure
SI1487541T1 (sl) Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
EP1466622A4 (en) MEDICAMENT AND METHOD FOR THE RECOVERY OF DISEASES RELATED TO VASCULAR DYSTONY
AU2003243708A1 (en) Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis
HK1085920A1 (en) Use of dihydroimidazolones for the manufacture of a medicament for the treatment of epilepsy in dogs
EP1520043A4 (en) METHOD FOR IDENTIFYING IKK ALPHA FUNCTION AND OTHER GENES FOR THE TREATMENT OF INFLAMMATORY DISEASES
HUP0303988A2 (hu) Azitromicin alkalmzása nem fertőző gyulladásos betegségek kezelésére szolgáló gyógyszerkészítmény előállítására
SI1487828T1 (sl) Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni
IL160780A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
AU2003235798A8 (en) Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
HUP0400222A3 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
AU2003252182A8 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
GB0004531D0 (en) The treatment of respiratory diseases
HK1076034A1 (en) Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
IL160782A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
PL362566A1 (en) Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003209542A8 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
SI1496884T1 (sl) Kombinacija antitrombotika in aspirina in njena uporaba za zdravljenje aterotromboticnih bolezni
IL162492A (en) Use of alkylphosphocholines for producing a medicament for the preventative treatment of protozoan diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110404